| Kathryn J Wood, | |
|
5257 S Wadsworth Blvd, Littleton, CO 80123-2228 | |
| (303) 743-5855 | |
| Not Available |
| Full Name | Kathryn J Wood |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 5257 S Wadsworth Blvd, Littleton, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013050566 | NPI | - | NPPES |
| 003331 | Other | KAISER-COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 76113 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn J Wood, 2491 S Zinnia Way, Lakewood, CO 80228-4944 Ph: (303) 422-1166 | Kathryn J Wood, 5257 S Wadsworth Blvd, Littleton, CO 80123-2228 Ph: (303) 743-5855 |
News Archive
Mirina Corporation, a privately held biotechnology company focused on the generation of novel microRNA (miRNA) therapeutics with improved properties, announced today that it has closed a Series A-1 financing. The round was led by new investor Versant Ventures. Previous investors Alexandria Real Estate Equities, ARCH Venture Partners, OVP Venture Partners and WRF Capital also participated in the round. In conjunction with this financing, Brian Atwood, Managing Director of Versant Ventures, will join the Board of Directors.
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today the online publication of the results from the CLARITY Phase III trial using Cladribine Tablets (EMD Serono's proprietary investigational oral formulation of cladribine) in The New England Journal of Medicine. The CLARITY study was a two-year (96-week), randomized, double-blind, placebo-controlled Phase III trial of Cladribine Tablets in 1,326 people with relapsing-remitting multiple sclerosis (MS).
In a new study published in the esteemed journal JAMA researchers at Karolinska Institutet and Karolinska University Hospital have examined the association between a positive SARS-CoV-2 test during pregnancy and complications in mothers and their newborn babies.
Children born with a complete absence of the external ear canal, even if only one ear is affected, are more likely than their peers to struggle in school, according to new research at Washington University School of Medicine in St. Louis.
The Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates.
› Verified 4 days ago
Dr. Erin Elizabeth Riggle, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 W Dry Creek Cir, Littleton, CO 80120 Phone: 303-952-1100 Fax: 303-952-8185 | |
William T Gipson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1420 W Canal Ct, Ste 100, Littleton, CO 80120 Phone: 303-791-7540 Fax: 303-791-2241 | |
James Young Rhee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Southpark Dr, Littleton, CO 80120 Phone: 303-722-8987 Fax: 303-722-2935 | |
Sheanna L Barclay, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7600 Shaffer Pkwy, Littleton, CO 80127 Phone: 303-338-4545 | |
Mary S Todd, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5257 S Wadsworth Blvd, Littleton, CO 80123 Phone: 303-743-5855 | |
Lea A Craig, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Littleton, CO 80122 Phone: 303-850-5868 |